CompletedNCT04016779
This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication SPN-812 can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Condition
- ADHD
CompletedNCT03080259
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 13 Years to 18 Years
- Countries
- United States
- Sponsor
- University of Pittsburgh
- Condition
- ADHD
CompletedNCT04398225
This study exists to better understand the safety of this type of care and how manageable it feels in practice. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 4 Years to 12 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT02829970
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 18 Years to 24 Years
- Countries
- United States
- Sponsor
- University of Maryland, College Park
- Condition
- ADHD
CompletedNCT01322646
This study exists to understand how the medication Interventions holds up over time after the earliest research stage. Researchers are trying to understand whether the medication Interventions can give earlier or clearer feedback during care.
ADHDOtherFrom 16 Years to 18 Years
- Countries
- United States
- Sponsor
- State University of New York at Buffalo
- Condition
- ADHD
CompletedNCT03690674
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 5 Years to 10 Years
- Countries
- United States
- Sponsor
- Seattle Children's Hospital
- Condition
- ADHD
CompletedNCT03393390
This study exists to compare options and see whether the medication Cognition offers something meaningfully different. Researchers are trying to understand whether the medication Cognition can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 6 Years to 18 Years
- Countries
- United States
- Sponsor
- University of Michigan
- Condition
- ADHD
CompletedNCT01458340
This study exists to understand whether the medication TD-9855 is both safe enough and useful enough to take further. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Theravance Biopharma
- Condition
- ADHD
TerminatedNCT03242772
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 36 Months to 131 Months
- Countries
- United States
- Sponsor
- Duke University
- Condition
- ADHD
CompletedNCT04386096
This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 11 Years to 15 Years
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Condition
- ADHD
CompletedNCT01883817
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 5 Years to 15 Years
- Countries
- United States
- Sponsor
- University of Cincinnati
- Condition
- ADHD
CompletedNCT03605680
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT00500071
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
ADHDOtherFrom 6 Years to 12 Years
- Countries
- United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT03628781
This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 5 Years to 12 Years
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Condition
- ADHD
CompletedNCT04027361
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
ADHDOtherFrom 18 Years to 25 Years
- Countries
- United States
- Sponsor
- Tris Pharma, Inc.
- Condition
- ADHD
CompletedNCT00486551
This study exists to compare options and see whether acceptance and commitment therapy, a talking treatment, offers something meaningfully different. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 11 Years to 16 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- ADHD
CompletedNCT04647903
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Vallon Pharmaceuticals, Inc.
- Condition
- ADHD
CompletedNCT01907360
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- United States
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
- Condition
- ADHD
TerminatedNCT03523663
This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 8 Years to 12 Years
- Countries
- United States
- Sponsor
- University of Wisconsin, Madison
- Condition
- ADHD
CompletedNCT02699086
This study exists to better understand the safety of the medication PDC-1421 and how manageable it feels in practice. Researchers are trying to understand whether the medication PDC-1421 can give earlier or clearer feedback during care.
ADHDOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- BioLite, Inc.
- Condition
- ADHD
CompletedNCT02470234
This study exists to explore whether the medication Methylphenidate could improve care and understanding. Researchers are trying to understand whether the medication Methylphenidate can give earlier or clearer feedback during care.
ADHDOtherFrom 4 Years to 5 Years
- Countries
- United States
- Sponsor
- Rhodes Pharmaceuticals, L.P.
- Condition
- ADHD
CompletedNCT04018794
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 11 Years to 15 Years
- Countries
- United States
- Sponsor
- University of California, San Francisco
- Condition
- ADHD
CompletedNCT02635035
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can better support energy, concentration, and everyday functioning.
ADHDOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- NYU Langone Health
- Condition
- ADHD
CompletedNCT02547428
This study exists to compare options and see whether the medication Centanafadine offers something meaningfully different. Researchers are trying to understand how people respond to the medication Centanafadine in practice and what may need to be adjusted.
ADHDOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT04648553
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.
ADHDOtherOver 9 Years
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Condition
- ADHD